Funds will be used for advancing Company’s novel therapeutic pipeline and enhancing its unique microbiome modulation platform technologies Ness Ziona, Israel - May 15, 2017 – BiomX Ltd., a leading microbiome therapeutics company, announced today that it has...

read more